Cancer Neoantigens: A Promising Source of Immunogens for Cancer Immunotherapy

Ayumu Ito¹, Shigehisa Kitano^2,3*, Yongji Kim⁴, Moeko Inoue³, Masanori Fuse³, Kohei Tada³ and Kiyoshi Yoshimura^2,3

¹Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan, E-mail: EPOC_office@ncc.go.jp

²Department of Experimental Therapeutics, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan, E-mail: EPOC_office@ncc.go.jp

³Division of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan, E-mail: EPOC_office@ncc.go.jp

⁴Department of Orthopedic Surgery, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan, E-mail: EPOC_office@ncc.go.jp

^*Corresponding Author: Shigehisa Kitano, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan, Tel: +81-3-3542-2511, Fax: +81-3-3542-5228 Email: